Melittin |
5μM and 16μM |
|
bovine |
bovine heart MF1-ATPase |
|
|
Positive |
IC50 |
170 |
Nimesulide |
1 mM |
|
rat; Sprague-Dawley Crl:CD (SD) BR |
lung microsomes |
measurement of NADPH oxidation |
increase |
Positive |
p < 0.05 |
11 |
IF1 |
0.25 μM |
|
bovine |
bovine heart MF1-ATPase |
|
|
Positive |
IC50 |
170 |
IF1 |
1.2 μM |
|
bovine |
heart MF1-ATPase |
|
|
Positive |
IC50 |
170 |
IF1 |
0.84 μM |
|
bovine |
heart MF1-ATPase |
|
|
Positive |
IC50 |
170 |
IF1 |
300 μg/mg protein (T. pyriformis SMP-ATPase) ; |
|
|
|
|
|
Positive |
IC50 |
170 |
IF1 |
34 μg/mg protein |
|
C. asciculate |
SMP-ATPase |
|
|
Positive |
IC50 |
170 |
IF1 |
0.24 μM |
|
rat |
liver MF1-ATPase |
|
|
Positive |
Ki |
170 |
Enterostatin |
|
|
|
|
|
|
Positive |
|
170 |
ethyldimethylaminopropyl carbodiimide |
13 mol of EDC/mol F1 (EF1-ATPase) |
|
|
|
|
|
Positive |
95% inhibition |
170 |
1,5-difluoro-2,4-dinitrobenzene |
|
|
|
|
|
|
Positive |
|
170 |
Angiostatin |
|
|
|
|
|
|
Positive |
|
170 |
NBD-Cl |
|
|
|
|
|
|
Positive |
|
170 |
NBD-Cl |
|
|
|
|
|
|
Positive |
|
170 |
Gentamicin |
300 μg/ml |
1hr |
postnatal day 6 (P6±1d) FVB mice |
basal turn outer hair cells ( low-frequency processing OHCs) from intact cochlear (organ of Corti) explants |
scanning confocal microscope (NADH autofluorescence); T1 imaging buffer contained 5 mM glucose. T2 imaging buffer contained 10 mM glucose, 3 mM glutamate and 2 mM pyruvate. |
decrease |
Positive |
|
312 |
Troglitazone |
>25 µM |
1 and 2 hr |
|
HepG2 cells |
Cellular ATP concentrations were measured with a ATP Bioluminescent Somatic Cell Assay Kit |
decrease |
Positive |
|
332 |
Amitriptyline |
|
|
|
|
|
|
Positive |
|
197 |
Desipramine |
|
|
|
|
|
|
Positive |
|
197 |
lumiracoxib |
|
|
|
|
|
|
Positive |
|
197 |
Berberine |
25 μM |
48, 72 hr |
|
K1735-M2 mouse melanoma cells |
An acid extraction procedure was used to evaluate the intracellular concentration of adenine nucleotides. Adenine nucleotides were separated by reverse-phase high-performance liquid chromatography. Quantification was achieved by employing ATP, ADP, and AMP standard curves. |
decrease |
Positive |
p< 0.05 vs. control for each time of incubation |
327 |
Berberine |
10 μM |
24 hr |
|
K1735-M2 mouse melanoma cells |
An acid extraction procedure was used to evaluate the intracellular concentration of adenine nucleotides. Adenine nucleotides were separated by reverse-phase high-performance liquid chromatography. Quantification was achieved by employing ATP, ADP, and AMP standard curves. |
decrease |
Positive |
p< 0.05 vs. control for each time of incubation |
327 |
buformin |
62.5 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
decrease |
Positive |
p < 0.001 |
15 |
buformin |
62.5 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
decrease |
Positive |
p < 0.001 |
15 |
Phenformin |
62.5 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
decrease |
Positive |
p < 0.001 |
15 |
Phenformin |
62.5 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
decrease |
Positive |
p < 0.001 |
15 |
Metformin |
657 μM |
24 hours |
human |
hepatocytes |
Assay of Cellular ATP Content |
decrease |
Positive |
IC50 |
15 |
buformin |
26.1 μM |
24 hours |
human |
hepatocytes |
Assay of Cellular ATP Content |
decrease |
Positive |
IC50 |
15 |
Phenformin |
11.7 μM |
24 hours |
human |
hepatocytes |
Assay of Cellular ATP Content |
decrease |
Positive |
IC50 |
15 |
Metformin |
1430 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
decrease |
Positive |
IC50 |
15 |
buformin |
43.7 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
decrease |
Positive |
IC50 |
15 |
Phenformin |
12.9 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
decrease |
Positive |
IC50 |
15 |
Metformin |
> 2000 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
decrease |
Positive |
IC50 |
15 |
buformin |
> 500 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
decrease |
Positive |
IC50 |
15 |
Phenformin |
> 500 μM |
24 hours |
human |
HepG2 cells |
Assay of Cellular ATP Content |
decrease |
Positive |
IC50 |
15 |
Diazepam |
150μg/ml |
2hr |
|
PE cells |
luciferin-luciferase method |
decrease |
Positive |
|
293 |
Troglitazone |
|
|
human |
hepatocytes |
ATP bioluminescence assay |
decrease |
Positive |
|
226 |
Diclofenac |
50 μmol/L |
10 minutes |
rat |
liver mitochondria |
Measurement of Mitochondrial NADPH; incubated in the presence of Ca2+ |
increase |
Positive |
p < 0.01 |
6 |
Diclofenac |
250 μmol/L |
24 hours |
rat |
hepatocytes |
Assay of Cellular ATP contents; Assay of LDH leakage |
decrease |
Positive |
p < 0.01 |
6 |
Diclofenac |
500 μmol/L |
24 hours |
rat |
hepatocytes |
Assay of Cellular ATP contents; Assay of LDH leakage |
decrease |
Positive |
p < 0.01 |
6 |